Outlook Therapeutics (OTLK) Payables: 2015-2019
Historic Payables for Outlook Therapeutics (OTLK) over the last 5 years, with Sep 2019 value amounting to $5.9 million.
- Outlook Therapeutics' Payables rose 30.63% to $8.6 million in Q2 2020 from the same period last year, while for Jun 2020 it was $27.6 million, marking a year-over-year decrease of 15.96%. This contributed to the annual value of $5.9 million for FY2019, which is 28.36% down from last year.
- Per Outlook Therapeutics' latest filing, its Payables stood at $5.9 million for FY2019, which was down 28.36% from $8.2 million recorded in FY2018.
- In the past 5 years, Outlook Therapeutics' Payables ranged from a high of $27.8 million in FY2015 and a low of $5.9 million during FY2019.
- Over the past 3 years, Outlook Therapeutics' median Payables value was $8.2 million (recorded in 2018), while the average stood at $9.9 million.
- As far as peak fluctuations go, Outlook Therapeutics' Payables tumbled by 65.14% in 2016, and later skyrocketed by 60.75% in 2017.
- Outlook Therapeutics' Payables (Yearly) stood at $27.8 million in 2015, then crashed by 65.14% to $9.7 million in 2016, then surged by 60.75% to $15.6 million in 2017, then tumbled by 47.18% to $8.2 million in 2018, then decreased by 28.36% to $5.9 million in 2019.